You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bigner

Showing 1 - 25 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Glioma, Brain Tumor, Recurrent Trial in Durham (D2C7-IT)

Active, not recruiting
  • Malignant Glioma
  • Brain Tumor, Recurrent
  • Durham, North Carolina
    Preston Robert Tisch Brain Tumor Center at Duke
Jul 12, 2022

Newly Diagnosed MGMT Unmethylated Glioblastoma Trial in Durham (D2C7-IT, 2141-V11)

Not yet recruiting
  • Newly Diagnosed MGMT Unmethylated Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2023

Glioma, Malignant Trial in Durham (D2C7-IT, 2141-V11)

Recruiting
  • Glioma, Malignant
  • Durham, North Carolina
    Duke University Medical Center
Jul 27, 2022

Malignant Glioma Trial in Durham (D2C7-IT (6920 ng/mL via convection-enhanced delivery), Atezolizumab (1200 mg every three

Recruiting
  • Malignant Glioma
  • D2C7-IT (6920 ng/mL via convection-enhanced delivery)
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 22, 2022

Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous

Active, not recruiting
  • Malignant Neoplasms of Brain
  • tetanus toxoid
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • Stereotactic Radiosurgery
  • Lake Success, New York
    Northwell Health Brain Tumor Center
Feb 3, 2022

Gliomas Trial in Miami, Boston, New York (Nivolumab)

Active, not recruiting
  • Gliomas
  • Miami, Florida
  • +3 more
May 5, 2022

Lung Cancer, Ovarian Cancer, Uterine Cancer Trial in United States (OmniSeq Test)

Recruiting
  • Lung Cancer
  • +12 more
  • OmniSeq Test
  • Fort Payne, Alabama
  • +7 more
Jan 16, 2023

Invasive Breast Cancer Trial in Durham (PVSRIPO)

Recruiting
  • Invasive Breast Cancer
  • PVSRIPO
  • Durham, North Carolina
    Duke University Medical Center
Aug 4, 2021

Glioblastoma Multiforme Trial in Montréal (Metformin)

Active, not recruiting
  • Glioblastoma Multiforme
  • Montréal, Quebec, Canada
    Montreal Neurological Institute - McGill University Health Centr
Aug 31, 2022

Glioma Trial in Leiden, Rotterdam (device, combination product, other)

Recruiting
  • Glioma
  • Philips Achieva 7T MRI
  • +3 more
  • Leiden, Netherlands
  • +1 more
Aug 16, 2022

Synchronous Metastasized Breast Cancer, Circulating Tumor Cells Trial in Austria (Surgery, Surgery on Demand)

Active, not recruiting
  • Synchronous Metastasized Breast Cancer
  • Circulating Tumor Cells
  • Surgery
  • Surgery on Demand
  • Guessing, Burgenland, Austria
  • +13 more
May 24, 2022

Malignant Tumors Brain Trial in Durham (RNA-loaded dendritic cell vaccine, basiliximab)

Completed
  • Malignant Neoplasms Brain
  • Durham, North Carolina
    Duke University Medical Center
Mar 8, 2021

Multiple Myeloma Trial in Duarte, Boston, Portland (SL-401/ Pomalidomide/ Dexamethasone)

Terminated
  • Multiple Myeloma
  • SL-401/ Pomalidomide/ Dexamethasone
  • Duarte, California
  • +2 more
Jan 13, 2022

Advanced Solid Tumor, BRAF V600 Mutation Trial in Nanchang, Jinan, Shanghai (ABM-1310)

Not yet recruiting
  • Advanced Solid Tumor
  • BRAF V600 Mutation
  • Nanchang, Jiangxi, China
  • +2 more
Aug 12, 2022

Malignant Glioma Trial (PVSRIPO, Atezolizumab)

Withdrawn
  • Malignant Glioma
  • (no location specified)
Feb 7, 2020

Non GIST Sarcomas Trial in France (sunitinib)

Completed
  • Non GIST Sarcomas
  • Bordeaux, France
  • +5 more
Jan 3, 2022

Melanoma Trial in Durham (PVSRIPO, Nivolumab)

Withdrawn
  • Melanoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2020

Tumors Trial in France (Blood and tumor samples)

Recruiting
  • Neoplasms
  • Blood and tumor samples
  • Annecy, France
  • +5 more
Apr 8, 2022

Lungcancer Trial in Canada (Binimetinib, Pemetrexed, Carboplatin)

Completed
  • Lungcancer
  • Edmonton, Alberta, Canada
  • +3 more
Apr 1, 2021

Recurrent High-Grade Gliomas, Progressive Low-Grade Gliomas, Malignant Gliomas Trial run by the NCI (Steroids, ZD6474)

Completed
  • Recurrent High-Grade Gliomas
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 4, 2019

Glioma Trial run by the NCI (Enzastaurin (LY317615) monohydronchloride)

Terminated
  • Glioma
  • Enzastaurin (LY317615) monohydronchloride
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 4, 2019

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • cytogenetic analysis
  • La Jolla, California
  • +136 more
Aug 16, 2021

Glioblastoma, Glioblastoma Multiforme, Gliosarcoma Trial run by the NCI (topotecan, pazopanib)

Completed
Has Results
  • Glioblastoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 3, 2020

Melanoma Trial in Spain (vemurafenib and cobimetinib)

Completed
  • Melanoma
  • vemurafenib and cobimetinib
  • Donostia - San Sebastián, Guipuzcoa, Spain
  • +17 more
Feb 14, 2020